|
|||||
|
|
State of the art: using natriuretic peptide levels in clinical practice |
|
| Authors: | Maisel Alan Mueller Christian Adams Kirkwood Anker Stefan D Aspromonte Nadia Cleland John G F Cohen-Solal Alain Dahlstrom Ulf DeMaria Anthony Di Somma Salvatore Filippatos Gerasimos S Fonarow Gregg C Jourdain Patrick Komajda Michel Liu Peter P McDonagh Theresa McDonald Kenneth Mebazaa Alexandre Nieminen Markku S Peacock W Frank Tubaro Marco Valle Roberto Vanderhyden Marc Yancy Clyde W Zannad Faiez Braunwald Eugene |
| Affiliation: | VA San Diego Healthcare System, United States; University of California, San Diego, United States. |
| Abstract: | Natriuretic peptide (NP) levels (B-type natriuretic peptide (BNP) and N-terminal proBNP) are now widely used in clinical practice and cardiovascular research throughout the world and have been incorporated into most national and international cardiovascular guidelines for heart failure. The role of NP levels in state-of-the-art clinical practice is evolving rapidly. This paper reviews and highlights ten key messages to clinicians: |
| Keywords: | Natriuretic peptides Clinical practice Diagnosis |
| 本文献已被 PubMed 等数据库收录！ | |